Valuation : Guided Therapeutics, Inc.

Market Cap 21.72M 18.7M 17.56M 16.03M 30.11M 2.07B 30.33M 208M 80.96M 1.05B 81.56M 79.78M 3.47B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 24.6M 21.18M 19.89M 18.15M 34.1M 2.34B 34.34M 236M 91.68M 1.19B 92.35M 90.35M 3.93B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day-3.02%
1 week-10.00%
1 month-25.00%
3 months-1.75%
6 months-39.19%
Current year-58.33%
1 week 0.2
Extreme 0.2
0.24
1 month 0.18
Extreme 0.18
0.29
Current year 0.17
Extreme 0.17
0.54
1 year 0.15
Extreme 0.15
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 70 2016-11-30
Director/Board Member 76 2006-04-09
Chairman 67 2013-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
3/10/26 Free

Chairman

110,000 0.1316%
3/10/26 Others

Director

466,991 0.5586%
3/10/26 Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-10.00%-19.50%+50.00% 21.72M
-1.56%-2.96%+25.03%+9.39% 228B
-1.06%-2.02%+3.84%-20.32% 150B
-1.76%-0.08%-20.79%+19.70% 133B
-1.60%-4.50%-55.36%-11.20% 70B
-0.18%-0.12%+10.99%+18.83% 52.31B
+0.09%-2.62%-17.55%-14.96% 50.59B
-1.31%-1.77%+21.42%+24.71% 43.3B
-1.50%-1.00%+38.38%+46.00% 40.74B
-2.44%-0.50%-13.13%+47.87% 34.63B
Average -1.32%-1.68%-2.67%+17.00% 80.3B
Weighted average by Cap. -1.20%-1.02%+1.70%+7.17%

Financials

2024 2025
Net sales 7K 6.03K 5.66K 5.17K 9.7K 666K 9.77K 67.06K 26.09K 338K 26.28K 25.71K 1.12M 767K 660K 620K 566K 1.06M 72.98M 1.07M 7.35M 2.86M 37.01M 2.88M 2.82M 123M
Net income -2.42M -2.08M -1.95M -1.78M -3.35M -230M -3.37M -23.15M -9.01M -117M -9.08M -8.88M -386M -3.2M -2.75M -2.58M -2.36M -4.43M -304M -4.46M -30.62M -11.91M -154M -12M -11.74M -511M
Net Debt 1.77M 1.52M 1.43M 1.31M 2.46M 169M 2.47M 16.97M 6.6M 85.45M 6.65M 6.51M 283M 2.88M 2.48M 2.33M 2.12M 3.99M 274M 4.02M 27.55M 10.72M 139M 10.8M 10.56M 459M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-08-31 $0.2250 -3.02% 2,300
26-08-28 $0.2320 -1.28% 1,110
26-08-27 $0.2350 -6.00% 3,471
26-08-25 $0.2500 -.--% 74,645
  1. Stock Market
  2. Stocks
  3. GTHP Stock